Literature DB >> 22147446

A Bayesian order-restricted model for hormonal dynamics during menstrual cycles of healthy women.

Anindya Roy1, Michelle Danaher, Sunni L Mumford, Zhen Chen.   

Abstract

We propose a Bayesian framework for analyzing multivariate linear mixed effect models with linear constraints on the fixed effect parameters. The procedure can incorporate both firm and soft restrictions on the parameters and Bayesian model selection for the random effects. The framework is used to analyze data from the BioCycle study. One of the main objectives of the BioCycle study is to investigate the association between markers of oxidative stress and hormone levels during menstrual cycles of healthy women. Contrary to the popular belief that ovarian hormones are negatively associated with level of F (2) -isoprostanes, a known marker for oxidative stress, our analysis finds a positive association between ovarian hormone levels and isoprostane levels. The positive association corroborates the findings from a previous analysis of the BioCycle data.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147446     DOI: 10.1002/sim.4419

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Novel statistical methodology for analyzing longitudinal biomarker data.

Authors:  Paul S Albert; Enrique F Schisterman
Journal:  Stat Med       Date:  2012-09-28       Impact factor: 2.373

2.  Minkowski-Weyl Priors for Models With Parameter Constraints: An Analysis of the BioCycle Study.

Authors:  Michelle R Danaher; Anindya Roy; Zhen Chen; Sunni L Mumford; Enrique F Schisterman
Journal:  J Am Stat Assoc       Date:  2012-07-30       Impact factor: 5.033

3.  Higher serum iron is associated with increased oxidant stress in HIV-infected men.

Authors:  Matthew B Crist; Vlada V Melekhin; Aihua Bian; Ayumi Shintani; Ginger L Milne; Asha R Kallianpur; Leigh A Dageforde; David W Haas; Todd Hulgan
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.